Targeted treatment with somatostatin analogues (SA) in acromegaly and neuroendocrine neoplasms may have some benefits compared to curative treatments, because these agents decrease excessive hormone secretion exert a tumor-suppressive effect. Monotherapy combination therapy SA is well tolerated bears no risk of debilitating iatrogenic complications. In caused by somatotropin producing pituitary...